ArticleScientific reports2025
High risk HPV among HIV positive women with normal and abnormal cervical cytology in Bahir Dar, north west Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence of cervical human papillomavirus infections and cytological abnormalities in asymptomatic women living with HIV in Addis Ababa, Ethiopia.Scientific reports · 2026Article
- High-risk human papillomavirus and HBV, HCV, and T. pallidum association among women living with HIV in selected health facilities of Mekelle, Tigray, Northern Ethiopia.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is a malignant tumor that arises from the cells of the uterine cervix, primarily caused by persistent infection with human papillomavirus (HPV). Women living with HIV are at a heightened risk of infection with high-risk HPV types. This study aimed to determine the prevalence and type-specific distribution of HPV among HIV-positive women with cervical cytologic abnormalities in Bahir Dar, northwestern Ethiopia. A facility-based cross-sectional study was conducted among HIV-positive women in this region between January and March 2025. A total of 344 women were enrolled. Of these, 171 (49.7%) had a high-risk HPV (HR-HPV) infection. The type-specific distribution among the positive cases was as follows: HPV16, 37 (21.6%); HPV18, 15 (8.8%); HPV16 with other types, 24 (14.0%); HPV18 with other types, 7 (4.1%); both HPV16 and HPV18, 6 (3.5%); and other high-risk types, 82 (47.9%). Cytological analysis revealed that 81 women (23.55%) had abnormalities, while 263 (76.45%) had normal results. Among the abnormal cases, the findings were: 26 (32.1%) ASC-US, 22 (27.2%) LSIL, 14 (17.3%) ASC-H, 9 (11.1%) LSIL-H, and 10 (12.3%) HSIL. The study also found that HIV-positive women aged 31 and older had significantly higher odds of HR-HPV infection compared to younger women, with the peak risk observed in the 41-50 age group. Additional risk factors included higher parity, an early sexual debut, and having multiple sexual partners. Given the high prevalence of HR-HPV and its strong association with abnormal cytology, targeted preventive measures including enhanced screening, vaccination, and patient education are crucial for HIV-positive women, particularly in low-resource settings like northwestern Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.